A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review

The identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID‐19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.

Detalles Bibliográficos
Autores principales: Sheka, Maria, Coattrenec, Yann, Lorenzini, Kuntheavy Ing, Nendaz, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188898/
https://www.ncbi.nlm.nih.gov/pubmed/37207086
http://dx.doi.org/10.1002/ccr3.7184
Descripción
Sumario:The identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID‐19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.

Ejemplares similares